HealthOctober 1, 2005
New Bull's-Eyes for Drugs
A familiar class of cell-surface receptors turns out to offer an array of fresh targets that could yield new treatments for disorders ranging from HIV infection to obesity
Stories by Terry Kenakin
New Bull's-Eyes for Drugs
A familiar class of cell-surface receptors turns out to offer an array of fresh targets that could yield new treatments for disorders ranging from HIV infection to obesity